Ibrance / Reampla (palbociclib) 125 mg, 21 capsules, Pfizer Ibrance (palbociclib) is used for HR-positive, HER2-negative locally advanced or metastatic breast cancer. International medicine delivery within 4-5 days.Contact +380996042415.
Delivery methods
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
Payment methods
- Bank transfer to the settlement account after receiving the order
-
indications
- Ibrance is indicated for the treatment of hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:
- letrozole as initial hormonal therapy in postmenopausal women;
- Fulvestrant in women with disease progression after endocrine therapy.
- Indications for use in combination with letrozole was approved in accordance with the accelerated approval procedure based on progression-free survival. Full approval for this indication is subject to verification and description of clinical benefit in a confirmatory trial.
- Trade name:Ibrance / Reampla
- Chemical name:Palbociclib
- Dosage:125 mg
- Quantity:21
- Dosage form:Tablets
- Manufacturer:Pfizer
No reviews yet
